管与滤过手术IRIS登记研究:队列选择、随访及与随机对照试验的比较
该研究基于IRIS登记数据(2013-2017年)构建了419只眼的队列(滤过手术183眼,管植入236眼),均在接受过先前滤过手术和/或白内障摘除后行再次手术,并与TVT随机对照试验队列比较。结果显示IRIS队列中治疗组间在种族和随访完成率上存在显著差异,且IRIS队列的随访完成率低于RCT(85.6% vs 96.1%)。部分用于优化选择的数据在IRIS登记中不可用。
要点
- IRIS登记缺少部分优化队列选择所需的数据。
核心结论
- TVT IRIS登记队列在基线时存在多个治疗组间显著差异,而TVT随机对照试验队列则无此差异。
- TVT IRIS登记队列的随访质量劣于TVT随机对照试验。
- IRIS登记缺少部分用于优化选择眼的数据。
研究设计与样本
- 研究设计为随机对照试验与IRIS登记队列的比较性研究。
- IRIS登记队列纳入2013-2017年接受管植入或滤过手术且先前有滤过手术和/或白内障摘除的眼,共419眼(滤过手术183眼,管植入236眼)。
- 提取基线手术及随访至1年的临床和人口学特征,并与TVT RCT队列比较。
临床怎么用
- 使用IRIS登记数据模拟RCT时需注意治疗组间基线特征不平衡的可能。
- 登记数据的随访完成率可能低于RCT,解读结果时需考虑随访偏倚。
- IRIS登记缺少部分关键变量,可能限制队列选择的精确性。
局限性
- IRIS登记中部分用于优化选择眼的数据不可用。
- IRIS登记队列随访完成率低于RCT,可能影响结果可靠性。
- IRIS登记队列在基线时存在治疗组间显著差异,与RCT不同。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the feasibility of replicating a randomized controlled trial (RCT) with a cohort of eyes, from IRIS® Registry data, analogous to the Tube Versus Trabeculectomy (TVT) RCT cohort and compare characteristics and follow-up. DESIGN: Comparison of RCT and IRIS Registry cohorts and follow-up. METHODS: We identified a cohort of IRIS Registry eyes (2013-2017) that received either a glaucoma drainage implant (tube) or trabeculectomy after a previous trabeculectomy and/or cataract extraction; extracted clinical and demographic characteristics for baseline surgery and follow-up visits through 1 year; and compared treatment groups in the IRIS Registry cohort and this cohort to the TVT RCT cohort. RESULTS: The IRIS Registry cohort included 419 eyes: 183 (43.7%) trabeculectomy; 236 (56.3%) tube. There were significant differences between treatment groups, including race (White: trabeculectomy 61.8%, tube 44.9%; Black: trabeculectomy 20.8%, tube 35.6%; P = .003) and the percentage of follow-up visits completed (trabeculectomy 88.4%, tube 83.8%, P = .004). There were also significant differences between the TVT IRIS Registry cohort and the TVT RCT cohort in the percentage of follow-up visits completed (IRIS Registry 85.6%, RCT 96.1%, P < .001) and in the probability of having a 1-year follow-up visit (IRIS Registry 81.4%, RCT 89.2%, P = .011). CONCLUSION: The TVT IRIS Registry cohort had several significant treatment group differences at baseline, whereas there had been none in the TVT RCT cohort. Follow-up in the TVT IRIS Registry cohort was inferior to that of the TVT RCT. Some data needed to refine the selection of eyes for the cohort were not available in the IRIS Registry.
引用
- Vanner EA, Sun CQ, McSoley MJ, et al. The Tube Versus Trabeculectomy IRIS® Registry Study: Cohort Selection and Follow-up and Comparisons to the Randomized Controlled Trial. Am J Ophthalmol. 2020. PMID: 33306999. doi:10.1016/j.ajo.2020.11.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。